MS200647-0020/BREAST020

A Phase II, Multicenter, Open Label Study of Bintrafusp Alfa (M7824) Monotherapy in Participants With HMGA2-expressing Triple Negative Breast Cancer

Open at Saint-Cloud since : 19/03/2021
Target : Adult
Phase : Phase II

Trial description

The main purpose of this study is to evaluate bintrafusp alfa monotherapy in participants with triple negative breast cancer (TNBC) who express high levels of HMGA2 as determined by a centralized reverse transcriptase-polymerase chain reaction (RT-PCR) test.

Url of the trial

Main investigator

FRANCOIS-CLEMENT BIDARD

Professeur - Médecin

Contact